Bird flu, Avian influenza, Diabetes, Cholesterol, Caner, HIV

Medical News Today - Cholesterol (6 unread)

Karo Bio: Successful Phase II Study Expands The Potential For Eprotirome In Dyslipidemia Treatment

Posted: October 30th, 2008, 9:00am CDT

Karo Bio (STO:KARO) has successfully completed a 10 week phase IIb study with eprotirome given to dyslipidemia patients undergoing treatment with the cholesterol absorption inhibitor ezetimibe. Eprotirome induced a statistically significant and clinically relevant lowering of serum LDL-cholesterol, triglycerides and lipoprotein(a) and was safe and well tolerated. Data show that eprotirome in combination with ezetimibe can become an important treatment option for patients with dyslipidemia.
Pneumonia Death Less Likely In Statin Users

Posted: October 29th, 2008, 3:00am CDT

According to an article published in the October 27 issue of Archives of Internal Medicine, people who were hospitalized with pneumonia were less likely to die within 90 days afterward if they took cholesterol-lowering statins before hospitalization. In the last ten years, the United States and Europe have seen a 20 to 50% increase in pneumonia hospitalization rates. In addition, some 10 to 15% of pneumonia patients die from the disease.
Statins Show Promise For Blood Clot Prevention

Posted: October 28th, 2008, 3:00am CDT

Statins, the class of drugs commonly used for lowering cholesterol, are now showing promise at preventing deep vein thrombosis (DVT) or blood clots, an affliction that occurs in nearly 2 million Americans each year.
Statins Reduce Risk Of Alzheimer's Disease According To New Long-Term Prospective Study

Posted: October 21st, 2008, 8:00am CDT

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease. An important new study has found that ongoing statin drug use was associated with a 67% reduction in the risk of AD (Current Alzheimer Research 2008; 5: 416-421).
Lowering Cholesterol - Small Changes = Big Difference, Without Medicines

Posted: October 8th, 2008, 7:00am CDT

People can respond to dietary changes within four to six weeks. Lowering their low density lipoprotein (LDL) cholesterol by up to 30 percent can significantly reduce their risk of coronary heart disease. "If cholesterol reductions of these amounts can be achieved by changes in lifestyle... there may be no need for many patients to take cholesterol-lowering medicines," says Professor David Colquhoun, a cardiologist from Wesley Medical Centre in Brisbane.
Colorectal Cancer Risk Increased By Metabolic Syndrome

Posted: October 7th, 2008, 9:00am CDT

In a large U.S. population-based study presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome. Dr. Donald Garrow and Dr.

← September 2008 (18 items) November 2008 (22 items) →

My Health News » Medical News Today - Cholesterol » October 2008

Feeds

Medical News Today - Cholesterol (6 unread)

Karo Bio: Successful Phase II Study Expands The Potential For Eprotirome In Dyslipidemia Treatment

Posted: October 30th, 2008, 9:00am CDT

Pneumonia Death Less Likely In Statin Users

Posted: October 29th, 2008, 3:00am CDT

Statins Show Promise For Blood Clot Prevention

Posted: October 28th, 2008, 3:00am CDT

Statins Reduce Risk Of Alzheimer's Disease According To New Long-Term Prospective Study

Posted: October 21st, 2008, 8:00am CDT

Lowering Cholesterol - Small Changes = Big Difference, Without Medicines

Posted: October 8th, 2008, 7:00am CDT

Colorectal Cancer Risk Increased By Metabolic Syndrome

Posted: October 7th, 2008, 9:00am CDT